$Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia$

Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia

Podrobná bibliografie
Hlavní autoři:	Amarnani, R, Travis, S, Javaid, MK
Médium:	Journal article
Jazyk:	English
Vydáno:	Oxford University Press 2020

Podobné jednotky

Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia
Autor: Mike Lin, a další
Vydáno: (2022-11-01)

A Rare Case of Hypophosphataemic Osteomalacia in von Recklinghausen Neurofibromatosis
Autor: Yasmine Makhlouf, a další
Vydáno: (2021-05-01)

Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment
Autor: L Aliberti, a další
Vydáno: (2023-01-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
Autor: Magda Wojtuś, a další
Vydáno: (2023-07-01)

Selective blood sampling for FGF-23 in tumor-induced osteomalacia
Autor: Hans-Christof Schober, a další
Vydáno: (2017-10-01)

Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
Autor: Ramy H. Bishay, a další
Vydáno: (2017-01-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
Autor: S. S. Rodionova, a další
Vydáno: (2019-12-01)

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
Autor: Neeharika Nandam, a další
Vydáno: (2021-02-01)

Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
Autor: Seiji Fukumoto
Vydáno: (2014-06-01)

An image of a FGF-23-producing tumor resulting in osteomalacia
Autor: Marcelo Giacomini Louça, a další
Vydáno: (2024-06-01)

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption
Autor: Naoko Hidaka, a další
Vydáno: (2021-12-01)

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
Autor: A. S. Pushkareva, a další
Vydáno: (2022-05-01)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
Autor: Iris R. Hartley, a další
Vydáno: (2022-08-01)

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Autor: Hannan, F, a další
Vydáno: (2008)

De Novo Large Deletions in the <i>PHEX</i> Gene Caused X-Linked Hypophosphataemic Rickets in Two Italian Female Infants Successfully Treated with Burosumab
Autor: Carmine Pecoraro, a další
Vydáno: (2023-07-01)

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
Autor: Yuka Kinoshita, a další
Vydáno: (2019-06-01)

A Case of Acute Prosthesis Migration after Femoral Head Replacement due to Osteomalacia by FGF23-Induced Tumor
Autor: Shinya Hayashi, a další
Vydáno: (2012-01-01)

Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
Autor: Anke H. Hautmann, a další
Vydáno: (2014-01-01)

Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome
Autor: S. Kumar, a další
Vydáno: (2020-06-01)

Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: Case report
Autor: Daichi Miyaoka, a další
Vydáno: (2020-12-01)

FGF-23 transmitted tumor – induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature
Autor: Florian A. Frank, a další
Vydáno: (2022-04-01)

A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets
Autor: Carson Huynh, a další
Vydáno: (2022-12-01)

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
Autor: Yuichi Takashi, a další
Vydáno: (2022-12-01)

Predicting the impact of PHEX, FGF23 and DMP1 gene variants found in Malaysian Malay patients with Hypophosphataemic Rickets through in silico analysis of protein function and mRNA secondary structure
Autor: Razali, Nurul Nadirah, a další
Vydáno: (2019)

Windswept lower limb deformities in patients with hypophosphataemic rickets
Autor: Ali Al Kaissi, a další
Vydáno: (2013-12-01)

A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia
Autor: Trilok Shrivastava, MD, a další
Vydáno: (2021-04-01)

Tumor-induced osteomalacia
Autor: Zinan Yin, a další
Vydáno: (2018-12-01)

Tumor-induced osteomalacia
Autor: Pablo Florenzano, a další
Vydáno: (2017-12-01)

The role of narrowband ultraviolet B phototherapy in the treatment of refractory osteomalacia
Autor: João Teixeira, a další
Vydáno: (2024-10-01)

Long-term safety in adults with X-linked Hypophosphatemia (XLH) treated with Burosumab, a fully human monoclonal antibody against FGF23: Final results of a phase 3 trial
Autor: Peter Kamenický, a další
Vydáno: (2020-10-01)

Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasis.
Autor: Min Young Park, a další
Vydáno: (2024-01-01)

Seven novel mutations in the PEX gene indicate molecular heterogeneity for X-linked hypophosphataemic rickets.
Autor: Dixon, P, a další
Vydáno: (1996)

Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
Autor: Lillian Abebe, a další
Vydáno: (2024-03-01)

Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis.
Autor: Read, A, a další
Vydáno: (1986)

X-linked hypophosphataemic rickets due to pseudo-exons of the PHEX gene.
Autor: Christie, P, a další
Vydáno: (2000)

Bridging markers defining the map position of X linked hypophosphataemic rickets.
Autor: Thakker, R, a další
Vydáno: (1987)

Genetic basis of hereditary hypophosphataemic rickets and phenotype presentation in children and adults
Autor: Tavana, Nahid, a další
Vydáno: (2021)

Osteomalacia
Autor: Ricardo Cediel
Vydáno: (1958-09-01)

Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia.
Autor: Ai-Luen Wu, a další
Vydáno: (2013-01-01)

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking
Autor: Kanhasut, Karnpob, a další
Vydáno: (2023)